Intensive versus conventional insulin therapy in critically ill neurologic patients: still searching for the sweet spot

Neurocrit Care. 2010 Dec;13(3):295-8. doi: 10.1007/s12028-010-9458-7.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Central Nervous System Diseases / drug therapy*
  • Central Nervous System Diseases / mortality
  • Critical Care / methods
  • Critical Care / statistics & numerical data
  • Critical Illness / mortality
  • Humans
  • Hyperglycemia / drug therapy*
  • Hyperglycemia / mortality
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Insulin